Defy Medical vs Marek Health: MD-Led Clinic vs Coaching-Plus-Prescribing
Defy Medical and Marek Health are different shapes of TRT telehealth that overlap on premium positioning. Defy is a 16-year-old Tampa clinic with MD/DO physicians (often with endocrinology training), pay-per-service pricing, and willingness to customize protocols beyond standard testosterone monotherapy. Marek pairs prescribing clinicians with monthly coaching check-ins and runs a lab-heavy approach with quarterly bloodwork. The choice usually comes down to whether you want physician credentials and protocol depth (Defy) or a higher-touch coaching relationship between provider visits (Marek).
Defy Medical
3.6Established Tampa hormone clinic with MD/DO physicians and premium pricing
Marek Health
3.4Coaching-plus-prescribing model with lab-heavy hormone optimization
Reviewed by Designing Longevity Editorial·Last verified May 1, 2026
Bottom line
Defy Medical for users who specifically want MD/DO physicians and protocol customization (HCG, anastrozole, non-standard dosing). Marek Health for users who specifically want monthly coaching contact between provider visits. For most TRT telehealth users, Hone Health (not in this comparison) is the better default than either, with stronger trust signals and lower all-in cost; choose Defy or Marek when their specific differentiator is the binding need.
Side-by-side at a glance
Who wins for each use case
We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.
Physician credentials and protocol depth
Winner: Defy MedicalDefy uses MDs and DOs with documented endocrinology and hormone-optimization backgrounds. ExcelMale forum threads consistently cite individual Defy physicians (Dr. Calkins specifically) by name as the primary draw. Defy is documented as willing to customize protocols beyond standard testosterone monotherapy (HCG, anastrozole, non-standard dosing) when bloodwork warrants. Marek prescribes through clinicians but does not market the same physician-credential depth.
Operational track record
Winner: Defy MedicalDefy has been operating since 2009, 16 years of operational tenure as a hormone clinic. Marek is a younger entrant with smaller operational scale. For risk-averse users, Defy's longer history is the cleaner choice on this dimension.
BBB rating posture
Winner: Defy MedicalDefy carries a BBB C rating with one unanswered complaint and is NOT Accredited; the file has been open since 2016. Marek is also NOT BBB Accredited and has no posted letter grade at capture date. Defy at least has a public letter grade we can evaluate; Marek's profile is in the lab category with no rating to assess. Defy wins by having more visible BBB data, not by having a clean profile.
Care-model touch points between provider visits
Winner: Marek HealthMarek's defining feature is the coaching-plus-prescribing model: each patient has a named coach for monthly check-ins between provider visits, used for refills and protocol-refinement questions. Defy is pay-per-service with no comparable named-coach touch point. If high-touch contact between provider visits matters to you, Marek wins outright.
Trustpilot signal quality
Winner: Marek HealthMarek shows 4.8/5 across roughly 430-890 reviews depending on which Trustpilot mirror you reach (consistent rating across pages with no fraud notice). Defy shows 4-5 stars across roughly 3,800 reviews (also clean, no fraud notice). Both are strong, but Marek's rating consistency and the 4.8 figure tip this row in Marek's favor; the smaller sample is a real caveat.
Refill reliability
Winner: Marek HealthDefy has multiple ExcelMale forum threads documenting refill delays of up to two weeks at Defy, with users needing to follow up to push refills through. Marek's coaching model includes monthly check-ins that surface refill issues earlier in the cycle, and forum commentary does not document comparable refill-delay patterns. For users where frictionless refills matter, Marek is the cleaner pick.
Insurance and pharmacy flexibility
Winner: Marek HealthDefy will not fax prescriptions to outside pharmacies (Express Scripts, etc.), so even users whose commercial insurance would cover testosterone cannot use that benefit through Defy. Marek does not impose the same pharmacy restriction. Neither accepts insurance directly (cash-pay is standard in TRT telehealth), but Marek preserves pharmacy optionality that Defy closes off.
Pricing transparency
Winner: Defy MedicalDefy publishes detailed pay-per-service pricing breakdowns ($149-$350 initial consult, $200-$350/month medication, $200-$400 per quarterly lab panel via LabCorp). Marek publishes a $250 initial deposit, $225-$275/month medication, and $350-$700 per quarterly lab panel, but the lab-tier pricing variance ($350-$700) is wider and less predictable. Defy's pricing structure, while more expensive, is more granular and predictable.
Rubric scores side-by-side
Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.
Licensure 20% weight
Accreditation 20% weight
Transparency 20% weight
Product quality 15% weight
Pricing 15% weight
Customer service 10% weight
Pricing in plain terms
Both run cash-pay, lab-heavy models without insurance acceptance (HSA/FSA accepted on both, providing the standard 25-35% pre-tax discount). Defy: $149-$350 initial consult + $200-$350/month medication + $200-$400 per quarterly lab panel via LabCorp ($300-$450/month effective with prorated lab fees). Marek: $250 initial deposit + $225-$275/month medication + $350-$700 per quarterly lab panel ($300-$425/month effective). The headline monthly costs are similar; the difference is in lab-tier variance (Marek's panels run wider) and whether you value Defy's physician depth or Marek's coaching cadence.
Read the full profiles
This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.